Gold Biotechnology Revenue and Competitors

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Gold Biotechnology's estimated annual revenue is currently $2M per year.(i)
  • Gold Biotechnology's estimated revenue per employee is $155,000

Employee Data

  • Gold Biotechnology has 13 Employees.(i)
  • Gold Biotechnology grew their employee count by 0% last year.

Gold Biotechnology's People

NameTitleEmail/Phone
1
Director Website DevelopmentReveal Email/Phone
2
Director SalesReveal Email/Phone
3
Marketing DirectorReveal Email/Phone
4
Project & Database ManagerReveal Email/Phone
5
Account ManagerReveal Email/Phone
6
Account ManagerReveal Email/Phone
7
Account ManagerReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$79.1M5106%N/AN/A
#2
$1.1M717%N/AN/A
#3
$4.2M27-32%N/AN/A
#4
$2M1330%N/AN/A
#5
$4.3M284%N/AN/A
#6
$0.9M60%N/AN/A
#7
$5M323%N/AN/A
#8
$3.7M244%N/AN/A
#9
$0.3M40%N/AN/A
#10
$6M3950%N/AN/A
Add Company

What Is Gold Biotechnology?

Gold Biotechnology shares a vision with every researcher: Each facet of life science research will introduce us to a future of impactful discovery and learning, benefitting the entire world. And our vision will materialize sooner if a researcher’s passion is not sullied by worry over the quality of their reagents, especially the cost for quality. This is why we’re here! We believe in a future of change and prosperity, and we want to help you get there by being a resource for high-quality products at exceptional prices. By providing our customers with only the best chemicals possible, tested in GoldBio labs to assure our own quality specifications are met, you can be sure your research will go off without a hitch.

keywords:N/A

N/A

Total Funding

13

Number of Employees

$2M

Revenue (est)

0%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$0.4M13-24%$1.4M
#2
$1.6M13-55%N/A
#3
$1.7M1318%$1.5M
#4
$1.4M13-19%N/A
#5
$1.6M13-7%N/A